Innovative breast familiarity tool and guided self-exam app aim to make early awareness part of everyday self-care

MIAMI, FL / ACCESS Newswire / February 4, 2026 / In recognition of World Cancer Day, URLuminous is spotlighting its mission to transform breast health through awareness-first technology with the Luminous Pro Series and the Luminous Breast App - tools designed to help individuals and physicians build familiarity with breast health and encourage earlier medical follow-up when changes are detected. The Luminous Pro Series is currently used in various international markets and has received regulatory approval in the European Union, and the United Kingdom, reflecting its growing adoption in countries with robust health technology standards.

Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide, yet survival rates exceed 90% when the disease is detected early. URLuminous aims to close the gap between early detection and access by empowering individuals to take charge of their health and encouraging an awareness-first lifestyle.

The Luminous Pro Series - the first tool of its kind - uses patented light-based technology to illuminate soft tissue and blood flow in the breast, helping users better understand what is normal for their bodies and identify changes or potential anomalies over time. Designed for at-home use, the noninvasive device complements traditional screening methods by encouraging earlier awareness and proactive engagement. Areas that appear darker or shadowed may prompt users to seek further medical evaluation.

Supporting the device is the Luminous Breast App, a digital companion that guides users step by step through breast self-examination. Available on the Apple App Store and Google Play, the app reinforces URLuminous' commitment to accessibility by empowering individuals with education, guidance and consistency in their breast health routines.

URLuminous was founded by Marilyn Dans, a health tech innovator whose personal experience with a breast health scare at age 17 led to her mission of empowering women globally through access, education, and awareness-first tools. "What began as a simple idea has grown into a global platform centered on awareness. I believe that living an awareness lifestyle is key, and that early detection saves lives. If we can catch cancer early, we can save thousands of lives," says Dans.

This past October, URLuminous hosted a private presentation of the Luminous Pro device at the Wellington Hotel in Madrid, where key figures from the medical, business, and media worlds were in attendance. Among the guests were renowned general surgeon and breast pathology specialist Dr. Antonio Sierra, along with well-known personalities such as Alejandra Osborne and Marta López. The event highlighted the growing interest in awareness-first technology within Spain's medical and wellness community.

About URLuminous
URLuminous is a global breast health technology company dedicated to advancing early awareness through accessible, non-invasive tools. Founded by breast cancer survivor Marilyn Dans, the company developed the Luminous Pro Series and the Luminous Breast App to help individuals build familiarity with their breast health and encourage timely medical follow-up. URLuminous is currently available in the EU and U.K. and is preparing for expansion into the United States. For more information, visit URLuminous.com.

Media Contact:

TARA, Ink.
Gabriela Gutiérrez
Gigi@taraink.com

SOURCE: URLuminous